Gravar-mail: Engineering a Plasmin Inhibitor♦: Engineering Kunitz Domain 1 (KD1) of Human Tissue Factor Pathway Inhibitor-2 to Selectively Inhibit Fibrinolysis. Properties of KD1-L17R Variant